Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Little Green Pharma's share price for the quarter that ended in Sep. 2023 was A$0.165. Little Green Pharma's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 300.09 Mil. Therefore, Little Green Pharma's market cap for the quarter that ended in Sep. 2023 was A$49.52 Mil.
Little Green Pharma's quarterly market cap
declined
from Dec. 2021 (A$140.55 Mil) to Mar. 2023 (A$53.62 Mil) and
declined
from Mar. 2023 (A$53.62 Mil) to Sep. 2023 (A$49.52 Mil).
Little Green Pharma's annual market cap
increased
from Jun. 2020 (A$46.73 Mil) to Jun. 2021 (A$204.70 Mil) but then
declined
from Jun. 2021 (A$204.70 Mil) to Mar. 2023 (A$53.62 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Little Green Pharma's Enterprise Value for Today is A$41.60 Mil.
Little Green Pharma Market Cap Historical Data
The historical data trend for Little Green Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Little Green Pharma Annual Data
Trend
Jun19
Jun20
Jun21
Mar23
Market Cap
-
46.73
204.70
53.62
Little Green Pharma Semi-Annual Data
Jun20
Dec20
Jun21
Dec21
Mar23
Sep23
Market Cap
78.39
204.70
140.55
53.62
49.52
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Little Green Pharma Market Cap Distribution
For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Little Green Pharma's Market Cap falls into.
Little Green Pharma Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Little Green Pharma's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Little Green Pharma (ASX:LGP) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Little Green Pharma Market Cap Related Terms
Thank you for viewing the detailed overview of Little Green Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Little Green Pharma (ASX:LGP) Business Description
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). The company offers LGP-branded medicinal cannabis oil products in the Australian and European markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:LGP has been successfully added to your 